다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Psychiatry investigation, v.13 no.6, 2016년, pp.583 - 589
Lee, Ji Han (Washington University in St. Louis, St. Louis, MO, USA.) , Oh, Il-Hoan (The Catholic High-Performance Cell Therapy Center & Department of Medical Lifescience, The Catholic University of Korea, Seoul, Republic of Korea.) , Lim, Hyun Kook (Department of Psychiatry, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.)
AI-Helper
Alzheimer's disease (AD) without cure remains as a serious health issue in the modern society. The major neuropathological alterations in AD are characterized by chronic neuroinflammation and neuronal loss due to neurofibrillary tangles (NFTs) of abnormally hyperphosphorylated tau, plaques of β...
1 Zhagn L Li Z Alzheimer and the discovery of Alzheimer's disease Zhonghua Yi Shi Za Zhi 2014 44 288 290 25579215
2 Francis PT The interplay of neurotransmitters in Alzheimer's disease CNS Spectr 2005 10 11 Suppl 18 6 9
3 Marczynski TJ GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited Brain Res Bull 1998 45 341 379 9527011
4 Palmer AM Gershon S Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J 1990 4 2745 2752 2165009
5 Derouesne C Alzheimer and Alzheimer's disease: the present enlighted by the past. An historical approach Psychol Neuropsychiatr Vieil 2008 6 115 128 18556270
6 Reitz C Alzheimer's disease and the amyloid cascade hypothesis: a critical review Int J Alzheimers Dis 2012 2012 369808 22506132
7 Imtiaz B Tolppanen AM Kivipelto M Soininen H Future directions in Alzheimer's disease from risk factors to prevention Biochem Pharmacol 2014 88 661 670 24418410
8 Khan SS Bloom GS Tau: the center of a signaling nexus in Alzheimer's disease Front Neurosci 2016 10 31 26903798
9 Hahr JY Physiology of the Alzheimer's disease Med Hypotheses 2015 85 944 946 26386488
10 Parkin ET Watt NT Hussain I Eckman EA Eckman CB Manson JC Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein Proc Natl Acad Sci U S A 2007 104 11062 11067 17573534
11 Ronicke R Mikhaylova M Ronicke S Meinhardt J Schroder UH Fandrich M Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors Neurobiol Aging 2011 32 2219 2228 20133015
12 Berthelot K Cullin C Lecomte S What does make an amyloid toxic: morphology, structure or interaction with membrane? Biochimie 2013 95 12 19 22824150
13 Pallas M Camins A Molecular and biochemical features in Alzheimer's disease Curr Pharm Des 2006 12 4389 4408 17105434
14 Dickey CA Koren J Zhang YJ Xu YF Jinwal UK Birnbaum MJ Akt and CHIP coregulate tau degradation through coordinated interactions Proc Natl Acad Sci U S A 2008 105 3622 3627 18292230
15 Lindwall G Cole RD Phosphorylation affects the ability of tau protein to promote microtubule assembly J Biol Chem 1984 259 5301 5305 6425287
16 Amemori T Jendelova P Ruzicka J Urdzikova LM Sykova E Alzheimer's disease: mechanism and approach to cell therapy Int J Mol Sci 2015 16 26417 26451 26556341
17 Bateman RJ Aisen PS De Strooper B Fox NC Lemere CA Ringman JM Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease Alzheimers Res Ther 2011 3 1 21211070
18 Parihar MS Hemnani T Alzheimer's disease pathogenesis and therapeutic interventions J Clin Neurosci 2004 11 456 467 15177383
19 Cacquevel M Aeschbach L Houacine J Fraering PC Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified gamma-secretase complexes PLoS One 2012 7 e35133 22529981
20 Bradshaw EM Chibnik LB Keenan BT Ottoboni L Raj T Tang A CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology Nat Neurosci 2013 16 848 850 23708142
21 Griciuc A Serrano-Pozo A Parrado AR Lesinski AN Asselin CN Mullin K Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta Neuron 2013 78 631 643 23623698
22 Jones B Alzheimer disease: TREM2 linked to late-onset AD Nat Rev Neurol 2013 9 5 23208114
23 Selfridge JE E L Lu J Swerdlow RH Role of mitochondrial homeostasis and dynamics in Alzheimer's disease Neurobiol Dis 2013 51 3 12 22266017
24 Saharan S Mandal PK The emerging role of glutathione in Alzheimer's disease J Alzheimers Dis 2014 40 519 529 24496077
25 Resende R Moreira PI Proenca T Deshpande A Busciglio J Pereira C Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease Free Radic Biol Med 2008 44 2051 2057 18423383
26 Schroder M Kaufman RJ The mammalian unfolded protein response Annu Rev Biochem 2005 74 739 789 15952902
27 Taylor RC Dillin A Aging as an event of proteostasis collapse Cold Spring Harb Perspect Biol 2011 3
28 Urra H Dufey E Lisbona F Rojas-Rivera D Hetz C When ER stress reaches a dead end Biochim Biophys Acta 2013 1833 3507 3517 23988738
29 Ghosal K Vogt DL Liang M Shen Y Lamb BT Pimplikar SW Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain Proc Natl Acad Sci U S A 2009 106 18367 18372 19837693
30 Kakio A Nishimoto SI Yanagisawa K Kozutsumi Y Matsuzaki K Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid J Biol Chem 2001 276 24985 24990 11342534
31 Jacobsen KT Iverfeldt K O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-beta precursor protein (APP) Biochem Biophys Res Commun 2011 404 882 886 21182826
32 Liu F Iqbal K Grundke-Iqbal I Hart GW Gong CX O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease Proc Natl Acad Sci U S A 2004 101 10804 10809 15249677
33 Federico A Cardaioli E Da Pozzo P Formichi P Gallus GN Radi E Mitochondria, oxidative stress and neurodegeneration J Neurol Sci 2012 322 254 262 22669122
34 Luque-Contreras D Carvajal K Toral-Rios D Franco-Bocanegra D Campos-Peña V Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease? Oxid Med Cell Longev 2014 2014 497802 24683436
35 Confaloni A Tosto G Tata AM Promising therapies for Alzheimer's disease Curr Pharm Des 2016 22 2050 2056 26876218
36 Stella F Radanovic M Canineu PR de Paula VJ Forlenza OV Antidementia medications: current prescriptions in clinical practice and new agents in progress Ther Adv Drug Saf 2015 6 151 165 26301069
37 Godyn J Jonczyk J Panek D Malawska B Therapeutic strategies for Alzheimer's disease in clinical trials Pharmacol Rep 2016 68 127 138 26721364
38 Waite LM Treatment for Alzheimer's disease: has anything changed? Aust Prescr 2015 38 60 63 26648618
39 Ankarcrona M Winblad B Monteiro C Fearns C Powers ET Johansson J Current and future treatment of amyloid diseases J Intern Med 2016 280 177 202 27165517
40 Tong LM Fong H Huang Y Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives Exp Mol Med 2015 47 e151 25766620
41 Zhang F Jiang L Neuroinflammation in Alzheimer's disease Neuropsychiatr Dis Treat 2015 11 243 256 25673992
42 Zhang Y Li P Feng J Wu M Dysfunction of NMDA receptors in Alzheimer's disease Neurol Sci 2016 37 1039 1047 26971324
43 Aruga J Yokota N Mikoshiba K Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue Gene 2003 315 87 94 14557068
44 Han KA Jeon S Um JW Ko J Emergent Synapse Organizers: LAR-RPTPs and their Companions Int Rev Cell Mol Biol 2016 324 39 65 27017006
45 Um JW Ko J LAR-RPTPs: synaptic adhesion molecules that shape synapse development Trends Cell Biol 2013 23 465 475 23916315
46 Martinez-Morales PL Revilla A Ocana I Gonzalez C Sainz P Mc-Guire D Progress in stem cell therapy for major human neurological disorders Stem Cell Rev 2013 9 685 699 23681704
47 Bond AM Ming GL Song H Adult mammalian neural stem cells and neurogenesis: five decades later Cell Stem Cell 2015 17 385 395 26431181
48 Kim SU Lee HJ Kim YB Neural stem cell-based treatment for neurodegenerative diseases Neuropathology 2013 33 491 504 23384285
49 Oliveira AA Jr Hodges HM Alzheimer's disease and neural transplantation as prospective cell therapy Curr Alzheimer Res 2005 2 79 95 15977991
50 Park D Yang YH Bae DK Lee SH Yang G Kyung J Improvement of cognitive function and physical activity of aging mice by human neural stem cells over-expressing choline acetyltransferase Neurobiol Aging 2013 34 2639 2646 23731954
51 Xuan AG Long DH Gu HG Yang DD Hong LP Leng SL BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix Neurosci Lett 2008 440 331 335 18579298
52 Lanza RP Atala A Essentials of Stem Cell Biology, Second Edition Amsterdam Elsevier/Academic Press 2014
53 Phinney DG Prockop DJ Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views Stem Cells 2007 25 2896 2902 17901396
54 Bongso A Fong CY Gauthaman K Taking stem cells to the clinic: major challenges J Cell Biochem 2008 105 1352 1360 18980213
55 Oh IH Mesenchymal stromal cells: new insight on their identity and potential role in cell therapy Korean J Hematol 2010 45 219 221 21253420
56 Martin I De Boer J Sensebe L MSC Committee of the International Society for Cellular Therapy A relativity concept in mesenchymal stromal cell manufacturing Cytotherapy 2016 18 613 620 27059199
57 Sun C Shao J Su L Zhao J Bi J Yang S Cholinergic neuron-like cells derived from bone marrow stromal cells induced by tricyclodecane-9-yl-xanthogenate promote functional recovery and neural protection after spinal cord injury Cell Transplant 2013 22 961 975 23031841
58 Wu QY Li J Feng ZT Wang TH Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer's disease rat model Neurosci Lett 2007 417 281 285 17412501
59 Zhang L Tan X Dong C Zou L Zhao H Zhang X In vitro differentiation of human umbilical cord mesenchymal stem cells (hUC-MSCs), derived from Wharton's jelly, into choline acetyltransferase (ChAT)-positive cells Int J Dev Neurosci 2012 30 471 477 22683696
60 Takata K Kitamura Y Yanagisawa D Morikawa S Morita M Inubushi T Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats FEBS Lett 2007 581 475 478 17240371
61 Yun HM Kim HS Park KR Shin JM Kang AR il Lee K Placenta-derived mesenchymal stem cells improve memory dysfunction in an Abeta1-42-infused mouse model of Alzheimer's disease Cell Death Dis 2013 4 e958 24336078
62 Kim KS Kim HS Park JM Kim HW Park MK Lee HS Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model Neurobiol Aging 2013 34 2408 2420 23623603
63 Ding H Zhang H Ding H Li D Yi X Ma X Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response Cell Mol Immunol 2015 Inpress
64 Park HW Moon HE Kim HS Paek SL Kim Y Chang JW Human umbilical cord blood-derived mesenchymal stem cells improve functional recovery through thrombospondin1, pantraxin3, and vascular endothelial growth factor in the ischemic rat brain J Neurosci Res 2015 93 1814 1825 26332684
65 Zhou X Gu J Gu Y He M Bi Y Chen J Human umbilical cord-derived mesenchymal stem cells improve learning and memory function in hypoxic-ischemic brain-damaged rats via an IL-8-mediated secretion mechanism rather than differentiation pattern induction Cell Physiol Biochem 2015 35 2383 2401 25896602
66 Lerou P Embryonic stem cell derivation from human embryos Methods Mol Biol 2011 767 31 35 21822865
67 Kooreman NG Wu JC Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging J R Soc Interface 2010 7 Suppl 6 S753 S763 20880852
68 Ratajczak MZ Jadczyk T Pedziwiatr D Wojakowski W New advances in stem cell research: practical implications for regenerative medicine Pol Arch Med Wewn 2014 124 417 426 24956404
69 Araki R Uda M Hoki Y Sunayama M Nakamura M Ando S Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells Nature 2013 494 100 104 23302801
70 Tang J Xu H Fan X Li D Rancourt D Zhou G Embryonic stem cell-derived neural precursor cells improve memory dysfunction in Abeta(1-40) injured rats Neurosci Res 2008 62 86 96 18634835
71 Chen H Li Y Lin X Cui D Cui C Li H Functional disruption of human leukocyte antigen II in human embryonic stem cell Biol Res 2015 48 59 26506955
72 Jin X Lin T Xu Y Stem cell therapy and immunological rejection in animal models Curr Mol Pharmacol 2015 Inpress
73 Chambers SM Fasano CA Papapetrou EP Tomishima M Sadelain M Studer L Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat Biotechnol 2009 27 275 280 19252484
74 Cho MS Lee YE Kim JY Chung S Cho YH Kim DS Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells Proc Natl Acad Sci U S A 2008 105 3392 3397 18305158
75 Krencik R Weick JP Liu Y Zhang ZJ Zhang SC Specification of transplantable astroglial subtypes from human pluripotent stem cells Nat Biotechnol 2011 29 528 534 21602806
76 Kriks S Shim JW Piao J Ganat YM Wakeman DR Xie Z Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease Nature 2011 480 547 551 22056989
77 Lee H Shamy GA Elkabetz Y Schofield CM Harrsion NL Panagiotakos G Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons Stem Cells 2007 25 1931 1939 17478583
78 Auerbach SB Taking another look at the definition of an embryo: President Bush's criteria and the problematic application of federal regulations to human embryonic stem cells Emory Law J 2002 51 1557 1604 15212030
79 Liras A Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects J Transl Med 2010 8 131 21143967
80 Takahashi K Yamanaka S A developmental framework for induced pluripotency Development 2015 142 3274 3285 26443632
81 Yu J Vodyanik MA Smuga-Otto K Antosiewicz-Bourget J Frane JL Tian S Induced pluripotent stem cell lines derived from human somatic cells Science 2007 318 1917 1920 18029452
82 Fan X Sun D Tang X Cai Y Yin ZQ Xu H Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside Med Res Rev 2014 34 957 978 24500883
83 Chen M Huang J Yang X Liu B Zhang W Huang L Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming PLoS One 2012 7 e28203 22529890
84 Okita K Nakagawa M Hyenjong H Ichisaka T Yamanak S Generation of mouse induced pluripotent stem cells without viral vectors Science 2008 322 949 953 18845712
85 Stadtfeld M Nagaya M Utikal J Weir G Hochedlinger K Induced pluripotent stem cells generated without viral integration Science 2008 322 945 949 18818365
86 Bilic J Izpisua Belmonte JC Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 2012 30 33 41 22213481
87 Boland MJ Hazen JL Nazor KL Rodriguez AR Gifford W Martin G Adult mice generated from induced pluripotent stem cells Nature 2009 461 91 94 19672243
88 Kim J Efe JA Zhu S Talantova M Yuan X Wang S Direct reprogramming of mouse fibroblasts to neural progenitors Proc Natl Acad Sci U S A 2011 108 7838 7843 21521790
89 Zhao T Zhang ZN Rong Z Xu Y Immunogenicity of induced pluripotent stem cells Nature 2011 474 212 215 21572395
90 Yagi T Ito D Okada Y Akamatsu W Nihei Y Yoshizaki T Modeling familial Alzheimer's disease with induced pluripotent stem cells Hum Mol Genet 2011 20 4530 4539 21900357
91 Chin MH Mason MJ Xie W Volinia S Singer M Peterson C Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures Cell Stem Cell 2009 5 111 123 19570518
92 Marchetto MC Yeo GW Kainohana O Marsala M Gage FH Muotri AR Transcriptional signature and memory retention of human-induced pluripotent stem cells PLoS One 2009 4 e7076 19763270
93 Yuan SH Martin J Elia J Flippin J Paramban RI Hefferan MP Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells PLoS One 2011 6 e17540 21407814
94 Bock C Kiskinis E Verstappen G Gu H Boulting G Smith ZD Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines Cell 2011 144 439 452 21295703
95 Qu T Brannen CL Kim HM Sugaya K Human neural stem cells improve cognitive function of aged brain Neuroreport 2001 12 1127 1132 11338178
96 Zhou Q Brown J Kanarek A Rajagopal J Melton DA In vivo reprogramming of adult pancreatic exocrine cells to beta-cells Nature 2008 455 627 632 18754011
97 Puthiyedth N Riveros C Berretta R Moscato P Identification of differentially expressed genes through integrated study of Alzheimer's disease affected brain regions PLoS One 2016 11 e0152342 27050411
98 Roostaei T Nazeri A Felsky D De Jager PL Schneider JA Pollock BG Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease Mol Psychiatry 2016 Inpress
99 Jack CR Jr Knopman DS Chetelat G Dickson D Fagan AM Frisoni GB Suspected non-Alzheimer disease pathophysiology - concept and controversy Nat Rev Neurol 2016 12 117 124 26782335
100 Kondo T Asai M Tsukita K Kutok Y Ohsawa Y Sunada Y Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness Cell Stem Cell 2013 12 487 496 23434393
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.